CRISPR Gene Editing Has Been Used to Cure Mice of Sickle Cell Disease
by Jess Vilvestre
CORRECTING A MUTATION
Gene editing shows promise as a new treatment for sickle cell disease, according to a study published in the online journal Science Translational Medicine.
Experts from the University of California, Berkeley, UCSF Benioff Children’s Hospital Oakland Research Institute (CHORI), and the University of Utah School of Medicine have found success in correcting the blood cell mutation in tests of the blood of both mice and human sickle cell patients using CRISPR-Cas9, a genome “scissor” that can cut out and edit a DNA sequence.
After CRISPR was used to correct the mutated hematopoietic stem cells — precursor cells that mature into the hook-shaped hemoglobin characteristic of sickle cell disease, the corrected blood stem cells produced healthy hemoglobin. Following reintroduction into the mice, the genetically engineered stem cells remained in circulation for at least four months — a significant indication that any potential therapy would be lasting. Read more
Published by Futurism.com on October 12, 2016
‹ More News